BIOPORTO DIAGNOSTICS

About the BioPorto Team & Leadership... This website requires cookies to provide all of its features and uses IP-based tracking technologies for site visitors. For more information on what data is contained in cookies and which technologies are used, please see the Cookie and Site Usage Tracking Policy and Data Privacy Statement. By continuing to use this site, you agree with these policies and the Terms and Conditions... AKI is a silent epidemic among hospitalized patients-affecting more than 1 in 4 children i and 1 in 5 adults. ii Identify AKI early to inform treatment decisions, minimize unnecessary intervention, and improve patient outcomes.

Also known as: BioPorto, BioPorto Diagnostics A/S, BioPorto Diagnostics Inc, Bioporto US

Primary location: Chicago United States